{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:01Z","timestamp":1753891981622,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00890","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T04:46:35Z","timestamp":1591850795000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex"],"prefix":"10.3389","volume":"11","author":[{"given":"Dong-Dong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","article-title":"Mechanism-based concepts of size and maturity in pharmacokinetics","volume":"48","author":"Anderson","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.11.017","article-title":"Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex","volume":"105","author":"Ebrahimi-Fakhari","year":"2019","journal-title":"Pediatr. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0009-9236(97)90192-2","article-title":"Population pharmacokinetics of sirolimus in kidney transplant patients","volume":"61","author":"Ferron","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-017-0596-2","article-title":"mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders","volume":"12","author":"Franz","year":"2017","journal-title":"Orphanet. J. Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/bcp.13605","article-title":"Population pharmacokinetics of tacrolimus in children with nephrotic syndrome","volume":"84","author":"Hao","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2125.2009.03392.x","article-title":"Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients","volume":"68","author":"Jiao","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1432-1033.1997.00625.x","article-title":"Expression of CYP3A in the human liver\u2013evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth","volume":"247","author":"Lacroix","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/bcp.13181","article-title":"Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours: a report from the Children's Oncology Group","volume":"83","author":"Mizuno","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26470","article-title":"Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies","volume":"64","author":"Mizuno","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","article-title":"Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus","volume":"73","author":"Nathan","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/bcpt.13154","article-title":"Population pharmacokinetics and dosing regimen optimisation of lopinavir in Chinese adults infected with HIV","volume":"124","author":"Niu","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1016\/j.xphs.2019.09.019","article-title":"Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis","volume":"108","author":"Ren","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172872","article-title":"The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients","volume":"869","author":"Song","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1515\/dmpt-2016-0036","article-title":"Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients","volume":"32","author":"Tamashiro","year":"2017","journal-title":"Drug Metab. Pers. Ther."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02336-18","article-title":"Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants","volume":"63","author":"Tang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40272-019-00376-0","article-title":"Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex","volume":"22","author":"van der Poest Clement","year":"2020","journal-title":"Paediatr. Drugs."},{"key":"B22","first-page":"12302","article-title":"Population pharmacokinetics of sirolimus in pediatric tuberous sclerosis complex: from Real World Study","volume":"11","author":"Wang","year":"2018","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3892\/ol.2019.10562","article-title":"Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/00498254.2019.1651419","article-title":"Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients","volume":"50","author":"Wang","year":"2019","journal-title":"Xenobiotica"},{"key":"B25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/00498254.2019.1601791","article-title":"Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients","volume":"50","author":"Wang","year":"2020","journal-title":"Xenobiotica"},{"key":"B26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/FTD.0000000000000415","article-title":"Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers","volume":"39","author":"Zhang","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/08941939.2018.1447053","article-title":"Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis","volume":"32","author":"Zhang","year":"2019","journal-title":"J. Invest. Surg."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00890\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T04:46:36Z","timestamp":1591850796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00890\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":27,"alternative-id":["10.3389\/fphar.2020.00890"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00890","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"article-number":"890"}}